Reply to the letter to the editor: [Letter by Yue J, et al. regarding article ‘The relationship between atherogenic index of plasma and noreflow in patients with acute ST segment elevation myocardial infarction who underwent primary percutaneous coronary intervention’]
  
Yazarlar (9)
Muhammed Süleymanoğlu Sağlık Bilimleri Üniversitesi, Türkiye
Prof. Dr. İbrahim RENCÜZOĞULLARI Kafkas Üniversitesi, Türkiye
Prof. Dr. Yavuz KARABAĞ Kafkas Üniversitesi, Türkiye
Metin Çağdaş Kafkas Üniversitesi, Türkiye
Mahmut Yesin Kafkas Üniversitesi, Türkiye
Ayça Gümüşdağ Kafkas Üniversitesi, Türkiye
Makale Türü Açık Erişim Diğer (Teknik, not, yorum, vaka takdimi, editöre mektup, özet, kitap krıtiği, araştırma notu, bilirkişi raporu ve benzeri) (SCI, SSCI, AHCI, SCI-Exp dergilerinde yayınlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden makale)
Dergi Adı The International Journal of Cardiovascular Imaging (Q3)
Dergi ISSN 1569-5794 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 01-2021
Cilt / Sayı / Sayfa 37 / 1 / 3–4 DOI 10.1007/s10554-020-01919-0
Makale Linki http://link.springer.com/10.1007/s10554-020-01919-0
Özet
We have read with a great pleasure the letter of Yue J, et al. to the editor about our recent study which showed an association between atherogenic index of plasma and no-reflow in patients with ST segment elevation myocardial infarction who underwent primary percutaneous coronary intervention. Yue J, et al. raises concerns about the timing of blood collection, whether if it was taken before the emergency intervention or after. In emergency department, while performing intravenous line, the blood samples for blood biochemistry and whole blood count were also taken from the patients. Another concern of the author was the timing of left ventricular ejection fraction measurement (LVEF). LVEF measurements were obtained before the emergency intervention and some were after the intervention, but before the patient discharge. In our study we included the LVEF in our model, because we could not ignore that modeling which was comprehensively used in recent studies on relation of LVEF and no-reflow. We designed this statistical model not only for the no-reflow prediction but also for the explanation of the no-reflow pathophysiology. We thank the authors' letter for pointing out these issues that we hope to have addressed.
Anahtar Kelimeler